GlassScriptPhysician profile
Paul Michael
NPI 1477879229
$236,363.65
in general payments reported to CMS, 2019-2025
30 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63K · 2020: $38K · 2021: $28K · 2022: $60K · 2023: $44K · 2024: $3,250 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Long Term Medical Supply Or Device Loan: $10K · Food and Beverage: $2,823 · Travel and Lodging: $1,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,475.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,950.00 |
| Long Term Medical Supply Or Device Loan | $10,166.67 |
| Food and Beverage | $2,822.77 |
| Travel and Lodging | $1,712.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $85,854.03 | 2019-2025 | Jetstream Sc, Eluvia, Rotapro |
| Medtronic Vascular, INC. | $43,373.91 | 2019-2020 | |
| Surmodics, INC. | $25,480.36 | 2022-2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight |
| Abbott Laboratories | $24,398.24 | 2019-2024 | Supera, Perclose Prostyle, Esprit |
| Asahi Intecc USA, INC. | $19,526.78 | 2019-2022 | |
| Medtronic, INC. | $16,304.29 | 2021-2023 | Hawkone, Turbohawk, Abre |
| Angiodynamics, INC. | $15,471.67 | 2020-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Philips North America LLC | $3,416.05 | 2019-2021 | |
| Terumo Medical Corporation | $666.99 | 2019-2021 | |
| Novo Nordisk INC | $317.89 | 2021 | |
| Inari Medical, INC. | $201.31 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $181.09 | 2019-2023 | Xarelto |
| Siemens Medical Solutions USA, INC. | $136.68 | 2020-2021 | |
| Smith+Nephew, INC. | $125.00 | 2019 | |
| Shockwave Medical, INC | $122.50 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $118.97 | 2023 | |
| Abiomed | $100.40 | 2019 | |
| W. L. Gore & Associates, INC. | $100.39 | 2019 | |
| Intact Vascular, INC. | $80.16 | 2019 | |
| Corindus INC. | $68.27 | 2019 | |
| Djo, LLC | $63.76 | 2020 | |
| Ge Healthcare | $50.93 | 2019 | |
| Tactile Systems Technology INC | $45.77 | 2023 | Flexitouch Plus, Entre Plus |
| Organogenesis INC. | $34.30 | 2022 | |
| Bard Peripheral Vascular, INC. | $26.25 | 2022 | |
| Penumbra, INC. | $22.50 | 2025 | Indigo System |
| Biosense Webster, INC. | $21.57 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.80 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.25 | 2025 | Lifevest |
| Cashflow Solutions, LLC | $15.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.